This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.Find sources: "Cyclandelate" – news · newspapers · books · scholar · JSTOR (October 2021) (Learn how and when to remove this template message)
Cyclandelate
Clinical data
AHFS/Drugs.comMicromedex Detailed Consumer Information
ATC code
Identifiers
  • 3,3,5-trimethylcyclohexyl hydroxy(phenyl)acetate
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.006.611 Edit this at Wikidata
Chemical and physical data
FormulaC17H24O3
Molar mass276.376 g·mol−1
3D model (JSmol)
Melting point55 to 56.5 °C (131.0 to 133.7 °F)
Boiling point192 to 194 °C (378 to 381 °F) (14 mmHg)
  • O=C(OC1CC(CC(C1)(C)C)C)C(O)c2ccccc2
  • InChI=1S/C17H24O3/c1-12-9-14(11-17(2,3)10-12)20-16(19)15(18)13-7-5-4-6-8-13/h4-8,12,14-15,18H,9-11H2,1-3H3 checkY
  • Key:WZHCOOQXZCIUNC-UHFFFAOYSA-N checkY
  (verify)

Cyclandelate is a vasodilator used in the treatment of claudication, arteriosclerosis and Raynaud's disease.[1] It is also used to treat nighttime leg cramps, and has been investigated for its effect against migraine. It is orally administered.

References

  1. ^ Smith AL (January 1965). "Cyclandelate (Cyclospasmol) in the Treatment of Peripheral Circulatory Diseases". Angiology. 16: 1–7. doi:10.1177/000331976501600101. PMID 14258038.


Categories